Trial · NCT00301756
Adverse events22
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 22
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Treatment (Enzyme Inhibitor Therapy) | 28 | 32 | |
| other | Nausea | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 26 | 32 | |
| other | Lymphocyte count decreased | Investigations | Treatment (Enzyme Inhibitor Therapy) | 24 | 32 | |
| other | Constipation | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 23 | 32 | |
| serious | Pneumonitis | Respiratory, thoracic and mediastinal disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Fatigue | General disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Small intestinal obstruction | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 3 | 32 | |
| serious | Constipation | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 2 | 32 | |
| serious | Cytokine release syndrome | Immune system disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Small intestinal obstruction | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Arthralgia | Musculoskeletal and connective tissue disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Non-cardiac chest pain | General disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Hypotension | Vascular disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Pleural infection | Infections and infestations | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Urinary tract infection | Infections and infestations | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Abdominal pain | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Upper gastrointestinal hemorrhage | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Activated partial thromboplastin time prolonged | Investigations | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 | |
| serious | Dehydration | Metabolism and nutrition disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00301756/events